Comment on

• Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major.

  Olivieri NF, Brittenham GM, McLaren CE, Templeton DM, Cameron RG, McClelland RA, Burt AD, Fleming KA. Olivieri NF, et al. N Engl J Med. 1998 Aug 13;339(7):417-23. doi: 10.1056/NEJM199808133390701. N Engl J Med. 1998. PMID: 9700174 Clinical Trial.
• Iron-chelation therapy with oral deferiprone--toxicity or lack of efficacy?

  Kowdley KV, Kaplan MM. Kowdley KV, et al. N Engl J Med. 1998 Aug 13;339(7):468-9. doi: 10.1056/NEJM199808133390709. N Engl J Med. 1998. PMID: 9700182 No abstract available.
• Iron chelation with oral deferiprone in patients with thalassemia.

  Cohen AR, Martin MB. Cohen AR, et al. N Engl J Med. 1998 Dec 3;339(23):1713-4. doi: 10.1056/nejm199812033392320. N Engl J Med. 1998. PMID: 9867542 No abstract available.